Search Results for marijuana

Showing 1 – 9

FDA Seeks Comment on WHO Recommendations Restricting Certain Psychotropic Substances By Zachary Brennan - Published 10 January 2017

The Food and Drug Administration (FDA) on Tuesday offered a chance for those interested to submit written comments or request an informal public meeting on recommendations by the World Health Organization (WHO) to impose international manufacturing and distributing restrictions on certain drug substances.

Categories: News, US, FDA, WHO, Drugs, Government affairs, Product withdrawl and retirement

Tags: cannabis, marijuana, controlled substances, DEA

FOIA'd Documents Show FDA's Rationale Against Marijuana Rescheduling By Michael Mezher - Published 19 October 2016

In a report and other documents obtained by Vice News via the Freedom of Information Act (FOIA), the US Food and Drug Administration (FDA) lays out its case against rescheduling marijuana.

Categories: News, US, FDA, Drugs, Government affairs

Tags: Marijuana, Medical Marijuana, Schedule 1, Drug Enforcement Administration, Cannabis, Cannabinoid, Marinol

UK’s MHRA: Products Containing Cannabis Extract are Medicines By Zachary Brennan - Published 12 October 2016

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has recently come to the decision that products containing cannabidiol (CBD) are medicines, following a regulatory review of such products.

Categories: News, Europe, MHRA, Compliance, Drugs, Government affairs, Regulatory intelligence, Regulatory strategy

Tags: CBD, cannabis, marijuana, Cannabidiol, cannabinoids

Asia Regulatory Roundup: India Looks to Raise Drug Inspection Standards (20 October 2015) By Nick Paul Taylor - Published 20 October 2015

Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia.

Categories: News, India, Japan, Middle East, Oceania, CDSCO, PMDA, TGA, Drugs, Manufacturing, Quality, Regulatory intelligence, Regulatory strategy

Tags: CDSCO, DRAP, Pakistan, India, DCGI, marijuana, Australia

Canada's Medical Marijuana Regulations, An Overview By Rachelle D'Souza - Published 26 August 2015

This article presents an overview of Canada's medical marijuana regulations regarding individual prescription access and compliance measures for licensed producers.

Categories: Articles, Features, Canada, Health Canada

Tags: marijuana, medical marijuana, Canada, Health Canada

DEA to Allow Huge Increase in Marijuana Production to Meet Research Demands By Alexander Gaffney, RAC - Published 16 June 2015

The US Drug Enforcement Administration (DEA) has proposed a massive increase in the amount of marijuana it will allow to be produced this year in the hopes of meeting the demand of researchers studying new medicinal uses for the drug, it has announced.

Categories: News, US, Manufacturing, Research and development

Tags: DEA, Marijuana, Cannabidiol, Marihuana

DEA to Increase Marijuana Production Quota to Meet Demand of Medical Researchers By Alexander Gaffney, RAC - Published 07 April 2015

The US Drug Enforcement Administration (DEA) is proposing to more than triple the amount of marijuana it will allow to be produced this year in the hopes of meeting the demand of researchers studying new medicinal uses for the drug, it has announced.

Categories: News, US, Research and development

Tags: Medical Marijuana, Cannabidiol, DEA, Drug Enforcement Administration, Aggregate Production Quota

Up in Smoke: Canadian Regulators Find Pot too Potent By Michael Mezher - Published 13 February 2015

A licensed medical marijuana producer in Canada has issued a recall for its pot-based product, saying some batches of it are too strong.

Categories: News, Canada, Health Canada, Compliance, Government affairs, Labeling, Manufacturing

Tags: Medical Marijuana, Recalls, Labeling

As Medical Marijuana Hits Mainstream, Regulators Take Notice With Safety Recalls By Alexander Gaffney, RAC - Published 12 May 2014

Categories: Canada, Health Canada

Tags: Medical Marijuana, Contamination, Recall, Latest News